Business Description
Founded in Madrid in 1986, PharmaMar is a Spanish biopharmaceutical company that discovers and develops cancer treatments derived from marine organisms, selling its approved medicines across Europe, the United States, and other international markets. Its current product portfolio includes three approved drugs targeting soft tissue sarcoma, ovarian cancer, multiple myeloma, and small cell lung cancer, alongside several more candidates in active clinical trials. The company also pursues a separate line of research focused on silencing specific genes as a way to treat disease.
